However, contrary to this, intravenous or intra-arterial exogenous administration of IL-1α in subpathological doses offers neuroprotection and neurorestoration in both acute and subacute phases of experimental ischemic stroke [44]. The gene discussed is IL1A; the disease is ischemic stroke.